Exercise Rehabilitation in Veteran Cancer Survivors
Progressive Activity-Based Rehabilitation in Veteran Cancer Survivors With Chronic Pain
2 other identifiers
interventional
9
1 country
1
Brief Summary
Exercise rehabilitation has the potential as a non-pharmacological approach to reduce persistent neuropathic pain in Veterans with lung cancer. By examining the effects of exercise training in Veteran cancer survivors with NSCLC, there is the potential to revolutionize care for a: common, debilitating, and inadequately treated symptom in a growing population. This could lead to a larger investigation to fill critical gaps in the literature and at the same time help discover a new model of care for Veterans with chronic pain. The ultimate goal is to reduce this type of pain for the growing population of cancer survivors while simultaneously reducing the need for problematic opioid management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Aug 2019
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2018
CompletedFirst Posted
Study publicly available on registry
August 8, 2018
CompletedStudy Start
First participant enrolled
August 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
February 18, 2026
February 1, 2026
7.3 years
August 3, 2018
February 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Visual Analog Scale Change
Scale of 0 (no pain) to 100 (worst imaginable pain)
Measured at baseline, after 6 weeks control, and after 6 week intervention
Secondary Outcomes (3)
Patient-Reported Outcomes Measurement System Neuropathic Pain Quality (PROMIS-PQ Neuro) Change
Measured at baseline, after 6 weeks control, and after 6 week intervention
Fitness Change
Measured at baseline, after 6 weeks control, and after 6 week intervention
Strength Change
Measured at baseline, after 6 weeks control, and after 6 week intervention
Study Arms (2)
Control
OTHERParticipants maintain their current activity level.
Exercise Rehabilitation
ACTIVE COMPARATORParticipants will exercise 2x/week at training facilities and at home one day a week.
Interventions
This training is designed to improve fitness, target the major muscle groups for strength, and to improve balance. Aerobic exercise of walking on a treadmill will be performed. Thera-Bands will be used for resistance exercise for the lower and upper body. Balance program includes core exercises (stepping, weight shifts, etc.) and other progressive exercises.
Participants are instructed to maintain current activity level and are monitored for changes.
Eligibility Criteria
You may qualify if:
- Age 60-80 years
- Diagnosis with lung cancer
- History of treatment with either thoracotomy procedure or neurotoxic chemotherapy or both
- Completion of thoracotomy or chemotherapy \> or = 6 months
- Ability to walk on a treadmill
- Karnofsky performance status \> 70
- Score \> 1 Neuropathic Pain Scale
You may not qualify if:
- Presence of metastatic (stage IV)
- Life expectancy \< 6 months
- Musculoskeletal or medical conditions which preclude participation in an exercise program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VA Office of Research and Developmentlead
- Baltimore VA Medical Centercollaborator
Study Sites (1)
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, 21201, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alice S. Ryan, PhD
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2018
First Posted
August 8, 2018
Study Start
August 19, 2019
Primary Completion (Estimated)
December 20, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
February 18, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share